Pregnant women are susceptible to influenza because of hormonal and physiological changes in the body. During epidemics and pandemics, the incidence of influenza among pregnant women reaches 50%, and the number of fatal outcomes exceeds the general population rate by 2.4 times.
Просмотр содержимого документа
«Flu and Pregnancy»
Flu and Pregnancy
Goals and objectives
Goal: To study the impact of influenza on pregnancy Objectives: • To study the etiology, epidemiology and clinical presentation of influenza • To review diagnostic methods • To investigate the course of the disease in pregnant women
What is ARVI?
ARVI refers to a group of viral infections affecting the respiratory tract.
Types of Viruses
• Influenza virus
• Rhinovirus
• Adenovirus
• Coronavirus
Common Symptoms of ARVI
- Cough
- Sore throat
- Fever
- Fatigue and body aches
Transmission
How is ARVI Spread?
- Airborne droplets from coughs and sneezes
- Touching contaminated surfaces
Diagnosis Diagnosis of ARVI
- Epidemiological data
- Clinical data – CBC (complete blood count) – Rapid test
- Serological methods – RTGA (hemagglutination inhibition test, HI) – RSK (complement fixation test, CFT) – RNGA (indirect hemagglutination assay, IHA) – RN (neutralization test, NT) – ELISA (enzyme‑linked immunosorbent assay) – PCR (polymerase chain reaction)
Complications
• ITSh (infectious-toxic shock) • Brain edema (cerebral swelling) • Acute cardiovascular insufficiency • Pulmonary edema • Acute respiratory failure • Bacterial complications (pneumonia, bronchitis, otitis, etc.)
Clinical features in pregnant women
• Prolonged course of ARVI (acute respiratory viral infection) without severe clinical manifestations • An attenuated (blunted) clinical presentation of ARVI is most characteristic
Complications in pregnant women
• More than a twofold increase in the development of placental insufficiency • Early onset of preeclampsia (gestosis) • Oligohydramnios (low amniotic fluid) • Threat of pregnancy loss/termination (17–26 weeks) • Intrauterine growth retardation and intrauterine fetal hypoxia • Hypoxic injury to the central nervous system (CNS) • Increased morbidity among newborns
2 L) • Dairy-and-vegetable diet • Detoxification therapy • Symptomatic therapy Etiotropic treatment: neuraminidase inhibitors, interferons, interferon inducers Contraindicated: – Tetracyclines – Doxycycline – Fluoroquinolones – Co-trimoxazole – Sulfonamides Etiotropic treatment: neuraminidase inhibitors, interferons, interferon inducers Contraindicated: – Tetracyclines – Doxycycline – Fluoroquinolones – Co-trimoxazole – Sulfonamides " width="640"
Treatment
• Bed rest while febrile • Alkaline fluids (2 L) • Dairy-and-vegetable diet • Detoxification therapy • Symptomatic therapy
- Etiotropic treatment: neuraminidase inhibitors, interferons, interferon inducers Contraindicated: – Tetracyclines – Doxycycline – Fluoroquinolones – Co-trimoxazole – Sulfonamides
- Etiotropic treatment: neuraminidase inhibitors, interferons, interferon inducers
- Contraindicated: – Tetracyclines – Doxycycline – Fluoroquinolones – Co-trimoxazole – Sulfonamides
Prevention Strategies
• Preventive Measures • Vaccination (e.g., flu vaccine) • Good hygiene practices (handwashing, masks) • Avoiding close contact with sick individuals
Conclusion
• Pregnant women are susceptible to influenza because of hormonal and physiological changes in the body. During epidemics and pandemics, the incidence of influenza among pregnant women reaches 50%, and the number of fatal outcomes exceeds the general population rate by 2.4 times. • With proper, timely treatment, at home or in hospital settings, the negative consequences for the mother and her baby are minimized.
Thank you for your attention!